Press release: Nexam’s patent application relating to catalysis of crosslinking approved in the USA.


Nexam has received a notice of allowance from the United States Patent and Trademark Office (USPTO) that it intends to grant Nexam’s US patent application relating to catalysis of crosslinking. The technology means that Nexam’s crosslinkers can be used in a wider temperature range and that the curing speed and temperature can be adjusted to specific applications. 

Nexam’s crosslinking technology, which includes a number of unique crosslinkers, results in improved processability of plastics at the same time as properties such as heat and chemical resistance is improved.

“In practice this means that Nexam’s crosslinking technology can be used in even more plastics and in an increased number of processes, which today has restrictions in e.g. getting to the right activation temperature. In short the catalysis technology enables an increased market potential and improved competitiveness for our crosslinking technology”, says Per Palmqvist Morin, CEO.

Nexam currently has 4 approved patents, as well as 40 patent applications within 11 patent families.

For more information on Nexam’s technology, please go to

Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.